Illinois General Assembly - Bill Status for HB2661

Amends the Alternative Health Care Delivery Act and the Hospital Licensing Act. Sets forth the General Assembly's findings concerning the screening of newborns for congenital heart defects. Provides that all birth centers and hospitals must test every newborn for congenital heart defects via a screening test in line with the current standard of care, such as pulse oximetry screening, according to congenital heart defect screening protocols developed by the Department of Public Health in consultation with relevant medical practitioners and stakeholders. Provides that exceptions to mandatory congenital heart defect screenings shall be limited to cases in which the parents object to the screening, or as directed by the congenital heart defect screening protocol.

Replaces everything after the enacting clause. Amends the Newborn Metabolic Screening Act. Provides that the Department of Public Health shall promulgate and enforce rules and regulations requiring that every newborn be subjected to tests for genetic, metabolic, and congenital anomalies as the Department may deem necessary (rather than tests for phenylketonuria, hypothyroidism, galactosemia and such other metabolic diseases as the Department may deem necessary from time to time). Deletes definitions of and references to "expanded screening" and "tandem mass spectrometer". Sets forth the General Assembly's finding concerning critical congenital heart disease. Provides that the Department of Public Health shall require that screening tests for critical congenital heart defects be performed at birthing hospitals and birth centers in accordance with a testing protocol adopted by the Department, by rule, in line with current standards of care, such as pulse oximetry screening, and may authorize screening tests for additional congenital anomalies to be performed at birthing hospitals and birth centers in accordance with a testing protocol adopted by the Department, by rule. Moves and makes changes to the provisions concerning collected specimens and a registry of cases. Moves the provisions concerning services and consultations and treatment formulas. Sets forth provisions concerning the Genetic and Metabolic Diseases Advisory Committee under the Genetic and Metabolic Diseases Advisory Committee Act. Provides that no new screening may begin prior to certain occurrences. Moves the provisions concerning lysosomal storage disorders, severe combined immunodeficiency disease, and mucopolysacchardosis disorders. Amends the Genetic and Metabolic Diseases Advisory Committee Act to provide that members of the Genetic and Metabolic Diseases Advisory Committee may receive compensation for necessary expenses incurred in the performance of their duties. Makes other changes. Effective immediately.

×